Rejaselindo
Beranda
PIT REJASELINDO 2024
Pendaftaran Anggota
Berita
Tentang Kami
Layanan
Galeri
Webinar
Rejaselindo
Beranda
PIT REJASELINDO 2024
Pendaftaran Anggota
Berita
Tentang Kami
Layanan
Galeri
Webinar
More
  • Beranda
  • PIT REJASELINDO 2024
  • Pendaftaran Anggota
  • Berita
  • Tentang Kami
  • Layanan
  • Galeri
  • Webinar
  • Beranda
  • PIT REJASELINDO 2024
  • Pendaftaran Anggota
  • Berita
  • Tentang Kami
  • Layanan
  • Galeri
  • Webinar

PIT REJASELINDO 2024

𝘽𝙚𝙮𝙤𝙣𝙙 𝙎𝙩𝙚𝙢 𝘾𝙚𝙡𝙡 : 𝙒𝙝𝙚𝙧𝙚 𝘼𝙧𝙚 𝙒𝙚?

 Perhimpunan Dokter Seminat Rekayasa Jaringan dan Terapi Sel Indonesia (REJASELINDO) sebagai organisasi 𝐫𝐞𝐬𝐦𝐢 keseminatan di bawah 𝐈𝐃𝐈 menyelenggarakan PIT REJASELINDO 2024 "𝘽𝙚𝙮𝙤𝙣𝙙 𝙎𝙩𝙚𝙢 𝘾𝙚𝙡𝙡 : 𝙒𝙝𝙚𝙧𝙚 𝘼𝙧𝙚 𝙒𝙚?" dalam rangkaian 𝘛𝘩𝘦 5𝘵𝘩 𝘈𝘯𝘯𝘶𝘢𝘭 𝘔𝘦𝘦𝘵𝘪𝘯𝘨 𝘰𝘧 𝘐𝘯𝘥𝘰𝘯𝘦𝘴𝘪𝘢 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘛𝘪𝘴𝘴𝘶𝘦 𝘌𝘯𝘨𝘪𝘯𝘦𝘦𝘳𝘪𝘯𝘨 𝘢𝘯𝘥 𝘊𝘦𝘭𝘭 𝘛𝘩𝘦𝘳𝘢𝘱𝘺 (𝘙𝘌𝘑𝘈𝘚𝘌𝘓𝘐𝘕𝘋𝘖) 𝘹 𝘛𝘩𝘦 8𝘵𝘩 𝘈𝘯𝘯𝘶𝘢𝘭 𝘔𝘦𝘦𝘵𝘪𝘯𝘨 𝘐𝘯𝘥𝘰𝘯𝘦𝘴𝘪𝘢 𝘛𝘪𝘴𝘴𝘶𝘦 𝘉𝘢𝘯𝘬 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯 (𝘗𝘌𝘙𝘉𝘈𝘑𝘐) 𝘹 𝘛𝘩𝘦 12𝘵𝘩 𝘈𝘯𝘯𝘶𝘢𝘭 𝘔𝘦𝘦𝘵𝘪𝘯𝘨 𝘐𝘯𝘥𝘰𝘯𝘦𝘴𝘪𝘢 𝘚𝘵𝘦𝘮 𝘊𝘦𝘭𝘭 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯 (ASPI), pada :


🗓️ 4-7 Desember 2024
📍Hotel Aryaduta, Jakarta


𝗥𝗮𝗻𝗴𝗸𝗮𝗶𝗮𝗻 𝗔𝗰𝗮𝗿𝗮 :
📚 𝘚𝘪𝘮𝘱𝘰𝘴𝘪𝘶𝘮 𝘐𝘭𝘮𝘪𝘢𝘩


📚 𝘞𝘰𝘳𝘬𝘴𝘩𝘰𝘱 

  1. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐀𝐃𝐕𝐀𝐍𝐂𝐄 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 𝐅𝐎𝐑 𝐈𝐍𝐓𝐄𝐑𝐍𝐈𝐒𝐓
  2. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐀𝐏𝐋𝐈𝐊𝐀𝐒𝐈 𝐒𝐄𝐊𝐑𝐄𝐓𝐎𝐌 𝐃𝐈 𝐁𝐈𝐃𝐀𝐍𝐆 𝐃𝐄𝐑𝐌𝐀𝐓𝐎𝐋𝐎𝐆𝐈
  3. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐀𝐃𝐕𝐀𝐍𝐂𝐄 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 𝐅𝐎𝐑 𝐍𝐄𝐔𝐑𝐎𝐋𝐎𝐆𝐈𝐒𝐓𝐒
  4. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐀𝐏𝐏𝐋𝐈𝐂𝐀𝐓𝐈𝐎𝐍 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 𝐈𝐍 𝐑𝐄𝐂𝐎𝐍𝐒𝐓𝐑𝐔𝐂𝐓𝐈𝐕𝐄 𝐀𝐄𝐒𝐓𝐇𝐄𝐓𝐈𝐂 𝐏𝐋𝐀𝐒𝐓𝐈𝐂 𝐒𝐔𝐑𝐆𝐄𝐑𝐘
  5. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐂𝐋𝐈𝐍𝐈𝐂𝐀𝐋 𝐀𝐏𝐏𝐋𝐈𝐂𝐀𝐓𝐈𝐎𝐍 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 𝐅𝐎𝐑 𝐆𝐄𝐍𝐄𝐑𝐀𝐋 𝐏𝐑𝐀𝐂𝐓𝐈𝐓𝐈𝐎𝐍𝐄𝐑
  6. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 "𝐁𝐀𝐒𝐈𝐂 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 : 𝐈𝐍𝐓𝐑𝐎𝐃𝐔𝐂𝐓𝐈𝐎𝐍 𝐓𝐎 𝐌𝐄𝐒𝐄𝐍𝐂𝐇𝐘𝐌𝐀𝐋 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋"
  7. 𝐇𝐀𝐍𝐃𝐒 𝐎𝐍 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 "𝐌𝐄𝐒𝐄𝐍𝐂𝐇𝐈𝐌𝐀𝐋 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋𝐒 : 𝐈𝐒𝐎𝐋𝐀𝐓𝐈𝐎𝐍, 𝐂𝐔𝐋𝐓𝐔𝐑𝐄, 𝐀𝐍𝐃 𝐂𝐇𝐀𝐑𝐀𝐂𝐓𝐄𝐑𝐈𝐙𝐀𝐓𝐈𝐎𝐍"
  8. 𝐁𝐄𝐘𝐎𝐍𝐃 𝐓𝐇𝐄 𝐁𝐀𝐒𝐈𝐂𝐒 : 𝐌𝐀𝐒𝐓𝐄𝐑𝐈𝐍𝐆 𝐓𝐇𝐄 𝐏𝐑𝐎𝐂𝐄𝐒𝐒𝐈𝐍𝐆 𝐎𝐅 𝐒𝐓𝐄𝐌 𝐂𝐄𝐋𝐋 𝐒𝐄𝐂𝐑𝐄𝐓𝐎𝐌𝐄 𝐓𝐎𝐖𝐀𝐑𝐃𝐒 𝐂𝐄𝐋𝐋-𝐅𝐑𝐄𝐄 𝐓𝐇𝐄𝐑𝐀𝐏𝐘
  9. 𝐖𝐎𝐑𝐊𝐒𝐇𝐎𝐏 𝐓𝐈𝐒𝐒𝐔𝐄 𝐁𝐀𝐍𝐊 𝐀𝐍𝐃 𝐓𝐈𝐒𝐒𝐔𝐄 𝐄𝐍𝐆𝐈𝐍𝐄𝐄𝐑𝐈𝐍𝐆


📰 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘵𝘪𝘤 𝘊𝘰𝘮𝘱𝘦𝘵𝘪𝘵𝘪𝘰𝘯 : http://bit.ly/CompetitionRejaselindo2024


𝙇𝙄𝙉𝙆 𝙋𝙀𝙉𝘿𝘼𝙁𝙏𝘼𝙍𝘼𝙉 SIMPOSIUM DAN WS : https://bit.ly/PITREJASELINDO2024


ɪɴғᴏʀᴍᴀsɪ ʟᴇʙɪʜ ʟᴀɴᴊᴜᴛ : 085158811811 (ᴅʀ. ᴘᴜᴛʀᴀ)


ᴡᴡᴡ.ʀᴇᴊᴀsᴇʟɪɴᴅᴏ.ᴄᴏᴍ
@ʀᴇᴊᴀsᴇʟɪɴᴅᴏ 

Rangkaian PIT REJASELINDO 2024

FORUM FOR CELL THERAPY & REGENERATIVE MEDICINE

TRANSFORMING GROWTH FACTOR BETA 1 LEVEL IN OSTEOARTHRITIS - Taipei Medical University

TAIPEI, Taiwan, July 2, 2023 — Renowned academic and orthopedic specialist, Dr. Bintang Soetjahjo, is set to light up the world of regenerative medicine with his cutting-edge insights at the upcoming "Forum for Cell Therapy and Regenerative Medicine," paving the way for an impactful exchange of scientific information.


As a senior lecturer at the Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Central Java, Indonesia, and an experienced orthopedic doctor at Dr. Moewardi General Hospital, Surakarta, Central Java, Indonesia, Dr. Soetjahjo will bring to the fore a wealth of knowledge and fresh perspectives on cartilage healing.


The event, hosted by the International PhD Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taiwan, and the Center for Cell Therapy, TMU hospital, will take place on-site on Thursday, July 6, 2023, from 1:10 PM to 3:00 PM at the First Meeting Room, 15F, United Medical Building (Rear Building), Xinyi Campus, Taipei Medical University (TMU), Taiwan.


Dr. Soetjahjo will be the invited speaker at the event and delve into the topic, "A comparison between transforming growth factor beta 1 level in osteoarthritis cartilage and healthy cartilage of human knee." Dr. Soetjahjo's interest in osteoarthritis and the healing potential of cartilage steered him toward this field of research, leading to ground-breaking in vivo studies, involving the use of secretomes from the Umbilical Cord for cartilage repair. These studies have played a pivotal role in shaping up the trajectory for future research.


With his expertise in stem cells orthopedic and adult reconstruction hip-knee orthopaedic consultancy, Dr. Soetjahjo is a valuable contributor to the field. He has been awarded by BRIN-Kalbe for his work on 'Translational Clinical Trial" for osteoarthritis cases with secretomes and is currently in the evaluation and data collection phase of this trial.


This free event extends an invitation to diaspora in Taipei, Taiwan, especially academics from Taipei Medical University, Taiwan, to join the discussion. To secure a spot, participants are required to register at least two days in advance by emailing d151109004 (at) tmu (dot) edu (dot) tw, including their full name, department, grade/year, student ID number, and a scanned copy of their valid identity card.

HIMBAUAN REJASELINDO [PENTING]

Dengan Hormat Melanjutkan adanya edaran dari PB IDI terkait adanya dinamika organisasi akhir-akhir ini, serta merespons adanya deklarasi dan organisasi Perkumpulan Dokter Seluruh Indonesia (PDSI) pada tanggal 27 April 2022, bersama ini kami selaku Pimpinan REJASELINDO, dengan ini menyampaikan pernyataan sebagai berikut: 

  1. REJASELINDO sebagai Perhimpunan Dokter Seminat Rekayasa Jaringan dan Terapi Sel Indonesia adalah organisasi PDSm (Perhimpunan Dokter Seminat) yang bernaung di bawah IDI (Ikatan Dokter Indonesia).
  2. Sehubungan hal tsb, kami meminta kepada seluruh anggota REJASELINDO untuk tetap solid, tidak terpecah belah, dan tidak terpancing oleh isu-isu negative yang dapat memecah belah profesi dan internal organisasi. 
  3. Menaati peraturan perundang-undangan yang berlaku, AA/ART IDI, AD/ART REJASELINDO, dan ORTALA IDI
  4. Tetap bersama dan Bersatu dalam Ikatan Dokter Indonesia, untuk itu kita akan menunggu perintah organisasi lebih lanjut dari PB IDI. 

Demikian kami sampaikan dan terima kasih. 

Surat Himbauan REJASELINDO 1 Mei 2022 (pdf)Download

Informasi Terbaru

Informasi & Pertanyaan :


  • PIC Pendaftaran Simposium & Workshop : dr. Putra Brillian D 0851-5881-1811
  • PIC Scientific Competition : Dr. dr. Reza Y. Purwoko, SpDVE. FINSDV. FAADV 0813-3310-1115
  • Admin Sekretariat REJASELINDO : dr. Abdurrahman Afa Haridhi 


Atau dapat melalui email rejaselindoindonesia@gmail.com 

  • Beranda

Copyright © 2024 Rejaselindo - All Rights Reserved

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept